Loading...
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach
INTRODUCTION: While atenolol is an effective antihypertensive agent, its use is also associated with adverse events including hyperglycemia and incident diabetes that may offset the benefits of blood pressure lowering. By combining metabolomic and genomic data acquired from hypertensive individuals...
Na minha lista:
| Udgivet i: | Metabolomics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5310671/ https://ncbi.nlm.nih.gov/pubmed/28217400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1076-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|